BSECompany Update▲ PositiveResults3 Aug 2026
Fabtech Technologies Ltd
Transcript of Earnings Call - July 2026
Fabtech Technologies Ltd reported a 10% year-on-year revenue growth and a full turnaround from a loss to a profit in Q1 FY27, despite a challenging global environment. The company's consolidated revenue stood at Rupees 74.98 crore, with a net profit of Rupees 4.21 crores and an EBITDA margin of 9%. The management attributed the turnaround to its geographical mix shifting towards higher value markets and a stellar performance from its Saudi operations.
BSECompany Update▲ PositiveResults3 Aug 2026
GPT Healthcare Ltd
Please find enclosed press release on UFR for Q1FY2027
GPT Healthcare Limited reported unaudited financial results for Q1FY27, with total income at Rs 128 crore, a growth of 18% y-o-y. EBITDA and PAT stood at Rs 26.2 crore and Rs 12.7 crore, respectively. The company maintained a competitive ARPOB and recorded steady improvement in occupancy rates. Key operational highlights included the completion of over 700+ renal transplants, launch of robotic knee surgery programme, and delivery of over 700 radiation therapy procedures.
BSEBoard MeetingResults3 Aug 2026
Platinum Industries Ltd
Platinum Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve and take on records the ....
Platinum Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 to consider and approve the unaudited financial results for the quarter ended on June 30, 2026.
BSEBoard MeetingResults3 Aug 2026
Ganon Products Ltd
We are hereby submitting the Outcome of Board Meeting held on 03rd August, 2026 for approval of unaudited financial results
Ganon Products Ltd has announced its unaudited financial results for the first quarter and three months ended on 30th June, 2026, with a net profit of ₹4.25 lakhs and earnings per share of ₹0.05.
BSECompany Update▲ PositiveResults3 Aug 2026
Strides Pharma Science Ltd
Transcript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
Strides Pharma Science Ltd reported Q1 FY27 results, with 13% YoY growth in topline, driven by broad-based contributions across its business, and maintained EBITDA margins at 18.2% despite additional operating and freight costs.
BSEBoard MeetingResults3 Aug 2026
Dr Agarwals Eye Hospital Ltd-$
Outcome of the proceedings of the Board Meeting held on August 03, 2026 is submitted.
Dr Agarwals Eye Hospital Ltd-$ announced the outcome of its Board Meeting held on August 03, 2026, where it considered and approved unaudited financial results for the quarter ended June 30, 2026, along with the re-appointment of Cost Auditors for the financial year 2026-27.
BSEBoard MeetingResults3 Aug 2026
Foseco Crucible (India) Ltd
In connection with above mentioned subject matter and pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (referred to ....
Foseco Crucible (India) Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also approved the dissolution of its Risk Management Committee. The company's board of directors has considered and approved the unaudited financial results, which are enclosed with the announcement. The company has also provided a limited review report from its statutory auditor, Deloitte Haskins & Sells LLP.
BSECompany UpdateResults3 Aug 2026
Nucleus Software Exports Ltd
Please Find enclosed herewith the Transcript for Investor Call held on July 31, 2026
Nucleus Software Exports Ltd announced its Q2 FY2026-27 earnings, with revenue at INR 210.4 crore, a 6.4% QoQ and 3.4% YoY growth. The company's EBITDA was INR 7.6 crore, with margins at 3.6%. The company also announced the launch of its new GA, FinnAxia, and the appointment of Bhavit Godiwala as Chief Customer Success Officer.
BSECompany UpdateResults3 Aug 2026
Avadh Sugar & Energy Ltd
Investor Presentation with respect to the Financial Highlights of the Company for the quarter ended 30th June 2026
Avadh Sugar & Energy Ltd has released an investor presentation for Q1FY27, highlighting its financial highlights and sustainability initiatives.
BSEBoard MeetingResults3 Aug 2026
Thomas Cook (India) Ltd
We are enclosing herewith the Outcome of Board Meeting held on August 3, 2026.
Thomas Cook (India) Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results at their meeting held on August 3, 2026. The results will be published in newspapers as prescribed.
BSEBoard MeetingResults3 Aug 2026
Chadha Papers Ltd
Chadha Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve inter-alia consider Partial Redemption ....
Chadha Papers Ltd has scheduled a board meeting on August 11, 2026, to consider partial redemption of 0.01% redeemable non-convertible, non-cumulative preference shares. The trading window for dealing in shares of the company will remain closed till two days from the declaration of unaudited financial results for the quarter ended August 14, 2026.
BSEBoard Meeting▼ NegativeResults3 Aug 2026
Amerise Biosciences Ltd
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of ....
Amerise Biosciences Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company's revenue from operations was Rs. 7.92 lakhs, with a profit before tax of Rs. (8.14) lakhs. The net loss after tax was Rs. (8.14) lakhs. The company's earnings per share (EPS) was (0.01) for the quarter.
BSEBoard MeetingResults3 Aug 2026
Sicagen India Ltd
Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....
Sicagen India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 to consider and approve the Un-audited Financial Results for the Quarter ended 30th June, 2026.
BSEBoard MeetingResults3 Aug 2026
Incredible Industries Ltd
Incredible Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Incredible Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 10/08/2026 to consider and approve the unaudited financial results for the quarter ended 30 June, 2026.
BSEBoard MeetingResults3 Aug 2026
Concord Drugs Ltd
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Quarterly Results
Concord Drugs Ltd has scheduled a board meeting on 10/08/2026 to consider and approve the un-audited financial results for the quarter ended 30/06/2026.
BSEOthersResults3 Aug 2026
K K Silk Mills Ltd
Annual Report for the FY 2025-26
K K Silk Mills Ltd has submitted its Annual Report for the FY 2025-26 and announced its 34th Annual General Meeting, scheduled for August 27, 2026. The report includes the company's vision, mission, and corporate information, including the board of directors and key managerial personnel.
BSECompany UpdateResults3 Aug 2026
Ethos Ltd
Monitoring Agency Report
Ethos Ltd has submitted a Monitoring Agency Report to the stock exchanges regarding the utilization of proceeds from its Rights Issue for the quarter ended June 30, 2026, as per SEBI regulations.
BSECompany Update▲ PositiveResults3 Aug 2026
GPT Healthcare Ltd
Please find Investor Presentation on UFR for Q1FY2027.
GPT Healthcare Ltd has submitted an investor presentation on its un-audited financial results for Q1FY2027, showing healthy operational performance with an increase in average revenue per occupied bed (ARPOB) to ₹42350 driven by improved clinical mix and operating efficiencies.
BSECompany Update▲ PositiveResults3 Aug 2026
Noida Toll Bridge Company Ltd
Please refer media release pertaining with Financial Results for the quarter ended June 30, 2026.
Noida Toll Bridge Company Ltd announced Q1FY27 financial results, with revenue increasing 15.51% to ₹ 12.81 crore and profit after tax (PAT) rising 28.92% to ₹ 5.33 crore. The company completed the second phase of carriageway upgradation and initiated a 5-year preventive maintenance program.
BSEBoard MeetingResults3 Aug 2026
Medi Assist Healthcare Services Ltd
Medi Assist Healthcare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve the unaudited ....
Medi Assist Healthcare Services Ltd has scheduled a board meeting on August 8, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has also scheduled an earnings call on August 10, 2026, to discuss the financial results.